Flexible stent

Abstract
A preferred embodiment of a stent provides a folded strut section that provides both structural rigidity and reduction in foreshortening of the stent mechanism. A flexible section provides flexibility for delivery of the stent mechanism. In a second embodiment, flexible section columns are angled with respect to each other, and to the longitudinal axis of the stent. These relatively flexible sections are oppositely phased in order to negate any torsion along their length. In yet another embodiment, the flexible connector can take on an undulating shape (like an “N”), but such that the longitudinal axis of the connector is not parallel with the longitudinal axis of the stent. Finally, a new method is disclosed for making stents. The method consists of performing a standard photochemical machining process of cutting, cleaning and coating the tube with a photoresist. However, unlike former methods, the photoresist image is developed on the surface of the cylindrical metallic tube, which results in a controlled variable etching rate at selected sites on the cylindrical metallic tube during the etching process. Further embodiments provide living hinge connectors and connections along the length of the radial strut member.
Description




BACKGROUND ART




A stent is commonly used as a tubular structure left inside the lumen of a duct to relieve an obstruction. Commonly, stents are inserted into the lumen in a non-expanded form and are then expanded autonomously (or with the aid of a second device) in situ. A typical method of expansion occurs through the use of a catheter mounted angioplasty balloon, which is inflated within the stenosed vessel or body passageway, in order to shear and disrupt the obstructions associated with the wall components of the vessel and to obtain an enlarged lumen.




In the absence of a stent, restenosis may occur as a result of elastic recoil of the stenotic lesion. Although a number of stent designs have been reported, these designs have suffered from a number of limitations. These include restrictions on the dimension of the stent.




Other stents are described as longitudinally flexible but consist of a plurality of cylindrical elements connected together. This design has at least one important disadvantage, for example, according to this design, protruding edges occur when the stent is flexed around a curve raising the possibility of inadvertent retention of the stent on plaque deposited on arterial walls. This may cause the stent to form emboli or move out of position and further cause damage to the interior lining of healthy vessels.




Thus, stents are known in the art. Such stents may be expanded during or just after balloon angioplasty. As a general rule, the manufacture of a stent will need to compromise axial flexibility in order to permit expansion and provide overall structural integrity.




Prior stents have had a first end and a second end with an intermediate section between the two ends. The stent further has a longitudinal axis and comprises a plurality of longitudinally disposed bands, wherein each band defines a generally continuous wave along a line segment parallel to the longitudinal axis. A plurality of links maintains the bands in a tubular structure. In a further embodiment of the invention, each longitudinally disposed band of the stent is connected, at a plurality of periodic locations, by a short circumferential link to an adjacent band. The wave associated with each of the bands has approximately the same fundamental spatial frequency in the intermediate section, and the bands are so disposed that the waves associated with them are spatially aligned so as to be generally in phase with one another. The spatial aligned bands are connected, at a plurality of periodic locations, by a short circumferential link to an adjacent band.




In particular, at each one of a first group of common axial positions, there is a circumferential link between each of a first set of adjacent pairs of bands.




At each one of a second group of common axial positions, there is a circumferential link between each of a second set of adjacent rows of bands, wherein, along the longitudinal axis, a common axial position occurs alternately in the first group and in the second group, and the first and second sets are selected so that a given band is linked to a neighboring band at only one of the first and second groups of common axial positions.




Furthermore, this stent can be modified to provide for bifurcated access, whereas the stent itself is uniform throughout. If the manufacturer designs such a stent to have an large enough opening, then it is possible to place the stent such that a pair of stents can be placed one through the other. In this fashion, the stents are capable of being placed at a bifurcation, without any welding or any special attachments. An interlocking mechanism can be incorporated into the stent design to cause the stent to interlock at the desired position during assembly of the device.




Further, a metallic stent has been designed which contains a repeating closed loop feature. The stent is designed such that the closed loop does not change dimensions during expansion. The composite stent is created by filling the area enclosed by the loops with a material that enhances clinical performance of the stent. The material may be a ceramic or a polymer, and may be permanent or absorbable, porous or nonporous and may contain one or more of the following: a therapeutic agent, a radio-opaque dye, a radioactive material, or a material capable of releasing a therapeutic agent, such as rapamycin, cladribine, heparin, nitrous oxide or any other know drugs, either alone or in combination.




It has been seen, however, that it may be desirable to provide for stents that have both flexibility to navigate a tortuous lesion as well as increased column strength to maintain the rigidity necessary after emplacement into the lumen of the body. The preferred designs tend to provide the flexibility via undulating longitudinal connectors. The rigidity is generally provided via the mechanism of slotted tubular stents. It is perceived that there may be mechanisms capable of enhancing the characteristics of these types of stents. Such a stent would be both flexible in delivery and rigid upon emplacement.




Furthermore, it is desirable to be able to produce stents in which the cross-sectional profile of either the struts or the connecting members is tapered (or variable) in size. In addition, it may be desirable to modify stents to have non-rectangular cross-sections. In both these cases, different manufacturing methods may aid in the creation of such stents.




SUMMARY OF THE INVENTION




It is an object of the invention to provide a stent having has relatively little foreshortening.




It is an object of the invention to provide a stent having an enhanced degree of flexibility.




It is an object of the invention to provide such a stent while diminishing any compromise in the stent's structural rigidity upon expansion.




It is a further object of the invention to provide a novel method for manufacturing stents.




These and other objects of the invention are described in the following specification. As described herein, a preferred embodiment of a stent provides for a device that contains a flexible section and a folded strut section. The folded strut section opens (like a flower) upon expansion. This folded strut section provides both structural rigidity and reduction in foreshortening of the stent mechanism. The flexible section provides flexibility for delivery of the stent mechanism.




In a second embodiment of the device, there is a columnar section and a flexible section. The columnar section provides for a device that lengthens in the longitudinal direction upon expansion. The flexible section provides for a section that shortens somewhat in the longitudinal direction upon expansion. As a result, there is no shortening or lengthening of the stent during expansion. The flexible section columns are angled, one with respect to the other, and also with respect to the longitudinal axis of the stent, in order to provide flexibility during delivery. This arrangement also to also provide additional resistance to the balloon to prevent “dogboning” of the stent on the balloon during delivery and slippage of the balloon along the stent. These relatively flexible sections are oppositely phased with respect to one another in order to negate any torsion along their length. These flexible sections can further be crimped onto the balloon catheter with a generally smaller profile than prior stent, so that the retention of the stent on the balloon is increased.




In yet another embodiment of the stent of the present invention, the flexible connector can take on an undulating shape (like an “N”), but such that the longitudinal axis of the connector is not parallel with the longitudinal axis of the stent. In this fashion, the flexibility is controlled in a pre-selected axis, which is not the longitudinal axis of the stent. Such an arrangement may be desired, for instance, when one chooses to place a stent in a particularly configured vasculature that has been predetermined by known means, such as intravascular ultrasound (“IVUS.”)




In still a further embodiment of the present invention, there are provided “living hinge” connectors, which connect the generally flexible connectors to the stronger radial strut members. These living hinges accomplish a number of the same characteristics found in the prior embodiments disclosed herein. First, because the living hinges tend to expand upon inflation, foreshortening of the length of the stent is further reduced. Second, there is a combined radial strength provided at the intersection between the living hinges and the radial strut members. This creates a small “hoop,” which is further resistant to kinking or collapse in situ. Third, as a corollary to the second attribute described above, the living hinge connectors provide for reduced strain along an equivalent length of stent.




In yet another preferred embodiment of the stent of the present invention, the connection point between the radial members and the connector members is moved to a position along the length of a radial strut. Typically, the connection may be placed at a position somewhere midway along the length of the strut. By moving the connection point of the flex connectors closer to the midpoint of the radial ring one can address foreshortening in an controlled fashion. In fact, balloon interaction aside, the connector does not have to stretch to compensate for foreshortening. When the flex connectors are connected at the midpoint of the radial ring, the distance/length through the middle portion of the stent between radial rings will remain unchanged. This is because the midpoint stays relativiely in the same position while the radial arcs of each strut move closer to the midpoint from both sides. By moving the location of the flex connector attachment beyond the mid-point of a strut, to the opposing side, one can actually capitilize on the strut moving closer to the midpoint and thus lengthen the stent upon expansion.




In addition, in the present embodiment described, adjacent radially rings start out of phase in the unexpanded state. Due to the diagonal oreintation of the connection points of the flexible connectors, upon expansion the radial rings tend to align themselves (“in” phase.) This results in more uniform cell space and thus improved scaffolding of the vessel. Further, there is described a “wavy” strut configuration, thereby facilitating both a reduced crimp profile for attaching the flexible connectors at or near a strut mid-point and reduced strain upon expansion, due to the strut itself contributing to a portion of the expansion.




Finally, a new method is disclosed for making stents. In this method there is novel photochemical machining of a cylindrical tube. The method consists of performing a standard photochemical machining process of cutting, cleaning and coating the tube with a photoresist. However, unlike former methods, the photoresist image is developed on the surface of the cylindrical metallic tube, which results in a controlled variable etching rate at selected sites on the cylindrical metallic tube during the etching process. The photoresist image consists of a series of circular regions of photoresist of varying diameters configured at varying distances along the stent. As the diameter of the circular photoresist pattern decreases and the distance between the circular photoresist patterns along the stent increases, the etch rate of the device increases. The photoresist pattern variation results in a variation in the metal removed during the etching process.




This process can be used to locally change the geometry of the cylindrical metallic tube. An advantage seen by this process is the ability to manufacture a tapered strut along the stent. Further, struts of cylindrical or other non-rectangular cross-section can be manufactured. In addition, surface contours can be placed on the stent, for instance, to allow for a reservoir to be placed in the stent to deliver drugs.




These and further objects of the invention will be seen from the following drawings and Detailed Description of the Invention.











DETAILED DESCRIPTION OF THE DRAWINGS





FIG. 1

is a plan view of a stent embodying the invention;





FIGS. 2 and 3

are plan views of an alternative embodiment of a stent of the invention;





FIG. 4

is a plan view of yet another embodiment of a stent of the invention;





FIG. 5

is a close up of the identified section of

FIG. 4

taken along lines b—b of

FIG. 4

;





FIG. 6

is a schematic of a photoresist pattern formed on the stent in order to perform a method for making the stent as described in the invention;





FIG. 7

is a plan view of yet another alternate embodiment of the present invention;





FIG. 8

is a plan view of a further alternate embodiment of the present invention; and





FIGS. 9 and 10

are schematics of the theory behind expansion of the stent of FIG.


8


.











DETAILED DESCRIPTION OF THE INVENTION




As can be seen in

FIG. 1

, there is described a cylindrical stent


10


which has a series of folded strut sections


20


connected by a series of flexible sections


30


. The folded strut sections


20


comprise a generally folded strut member


25


having a pair of ends


24


,


26


. Each of the pair of ends


24


,


26


is connected to another folded strut member


25


and also to the end of a flexible member


35


. Thus, each end


34


,


36


of a flexible member


35


is connected to two ends


24


,


26


of a folded strut


25


section member.




Each of the folded struts


25


takes on a generally irregular pattern. On the other hand, each of the flexible sections


35


takes on a generally undulating pattern. The folded strut sections


20


wrap circumferentially around the cylindrical shape of the stent


10


. Each flexible section


30


also connects to a folded strut section


20


around the circumference of the stent. It will be noticed that each adjacent flexible section


30


is positioned 180° out of phase with each other.




The longitudinal lengths of the folded struts


20


are short enough to give a smooth profile when the stent is bent. The folded strut


20


allows for a large diametrical expansion range upon expansion. So, upon expansion, the folded struts


20


expand circumferentially and become hoop-like so that maximum radial strength is achieved. The flexible members


30


placed between the folded struts improve the stent deliverability in the unexpanded dimension of the stent


10


. These flexible members are longitudinally compliant so that foreshortening is minimized upon expansion.




In use, therefore, the stent


10


of the present invention is placed on a balloon catheter and is snaked through the vasculature to be placed into a lesion site in an artery, typically a coronary artery. Because the flexible sections


30


are so substantially flexible, they are able to navigate tortuous lesions with relative ease. Once in place, the balloon catheter is expanded by conventional means. Upon expansion, the struts


25


in the folded strut sections


20


expand to obtain a hoop-like shape. In addition, these members expand longitudinally, so that any reduction in foreshortening is negated. Of course, upon expansion, the flexible members


35


straighten so that there is further strength achieved by the stent in the straightened and rigid positions.




A variation of the present invention can be seen in the stent


50


of

FIGS. 2

(“angled” version) and


3


(“straight” version). There, the radial strength sections


120


are achieved with generally straight members


115


, although these members do not have folded struts. Connection between generally straight members


115


is made by connecting the generally straight members


115


to the more flexible members


125


, much like the connection made involving the connecting members of the first embodiment of FIG.


1


.




The members that reduce foreshortening are angled members


130


which are seen to be 180° out of phase with one another. The connection between the flexible members is made at the end of a particular relatively non-flexible member and at the distal end of a particular angled canted member


130


. Now, when the columns comprised of relatively rigid members


115


expand, the length of these members


130


shorten. But, the longitudinal lengths of the canted members


130


are placed at an angle compared to the longitudinal axis of the stent


50


. So, upon expansion, these canted members


130


actually lengthen with respect to the longitudinal axis of the stent


50


. The net result is that no foreshortening occurs upon expansion of stent


50


.




The canted members


130


are angled in order to both: increase flexibility; and to provide additional resistance on the balloon surface. This arrangement helps prevent what is known as “dogboning” or exposure of leading edge of any of the strut members


75


contained at either end of the stent


50


. In addition, this configuration also prevents slippage of the stent along the balloon surface. The canted members


130


are canted in opposite phase (i.e., with a phase change of 180°) to one another, in order to negate any torsional effects on the struts


75


,


85


along the length of the stent. These particular members can be crimped to a lower profile than the more rigid members, in order to ensure increased retention of the stent on the surface of a balloon catheter. Further the configuration described herein has a uniquely folded configuration reducing any risk of “flaring” of the edges of struts


75


,


85


during traversal of the lumen.




It is to be noticed that the longitudinal position (the “order”) of the columns can be changed if one desires a smaller initial profile. That is, if one desires that the profile be smaller, it is possible to remove the more rigid sections


120


(or a portion thereof,) and replace them with the generally canted sections


130


.




It is also to be noticed that the wave amplitudes of the struts in a particular column are not kept constant. The wave amplitudes, defined herein as “W,” can be lengthened where permitted by the geometry. For instance, notice the space S created between one set of strut members A and a second set of strut members B. This particular configuration allows an increased expansion range around the unexpanded circumference of the stent, while maintaining an appropriate expansion area associated with the metallic struts placed around of the circumference of the stent. Such optimization of the strut surface area is important to ensure adequate coverage of the lesion upon expansion of the stent.




The stent


50


of this particular embodiment is expanded in much the same way as the stent


10


of FIG.


1


. When expansion occurs via the balloon catheter, the canted members


130


tend to lengthen and prevent foreshortening of the stent


50


; the relatively rigid members


120


tend to shorten in the longitudinal direction, but in so doing provide a greater rigidity for the fully expanded stent. It is to be understood however, that in the expansion of both stents


10


,


50


the ability to flexibly navigate the vasculature is enhanced from configuration of either stent


10


,


50


, as the case may be. All the while, the likelihood of stent foreshortening upon expansion is greatly reduced.




As can be seen in

FIG. 4

, one can also provide for a stent


175


that does not contain canted sections. Yet, the stent


175


expands with decreased foreshortening along its length due to the unique geometry of the stent


175


. Here, the stent struts


180


,


190


provide for a relatively constant length along the longitudinal axis. (In other words, the longitudinal dimension of the struts


180


,


190


in combination remains relatively constant, whether in the expanded or unexpanded condition.) In this fashion, upon expansion, the stent


175


maintains a generally constant length in any of its expanded, unexpanded or partially expanded conditions.





FIGS. 4 and 5

show yet another embodiment of the design of a similar stent


200


. Here, the connector


250


is shaped like an “N,” much after the same fashion of “N”-shaped connectors found commercially in the Bx Velocity® stent sold by Cordis Corporation, Miami Lakes Fla. and which is at least somewhat characterized in Ser. No. 09/192,101, filed Nov. 13, 2000, now U.S. Pat. No. 6,190,403 B1, and Ser. No. 09/636,071, filed Aug. 10, 2000, both of which are assigned to Cordis Corporation, and incorporated herein by reference.




In the stent


200


, the relatively rigid sections R contain unequal struts


210


,


220


of lengths a, b, as can best be seen in FIG.


4


. Moreover, as can be seen in

FIG. 5

, this strut pattern is formed so that the attachment points a at the end of the flexible connectors


250


can be located at any point along the struts


210


,


220


rigid section. In this fashion, when the stent is expanded, the relatively more rigid section R “holds” the connector


250


along the surface of the lesion, so that tenacity of the stent, and its concomitant support are both maintained to a high degree at the situs of the lesion. Yet, in the unexpanded configuration, the “N”-shaped flexible connectors


250


are able to guide the stent


200


around the curvature of generally any tortuous vessel, including tortuous coronary arteries.




As can be seen from

FIGS. 4 and 5

, the alternative embodiment stent


200


is also capable of reducing foreshortening along its entire length. This stent contains relatively rigid sections R and relatively flexible sections F containing connectors


250


. (The flexible sections F are in the form of undulating longitudinal connectors


250


.) The relatively rigid sections R generally contain a slotted form, created with struts


210


,


220


around a slot S. The relatively rigid sections R contain these interlaced struts


210


,


220


, which are of varying longitudinal dimensional length.




As can be seen from the figures, in some radial positions, the struts


210


are made longer. In other radial positions, the struts


220


are made shorter. However, the shorter struts


220


are of a constant length b in the longitudinal dimension, and in the fashion in which they connect to the relatively flexible connectors


250


. Also, as described above, the relatively more rigid sections R maintain the relatively more flexible sections F at a generally constant longitudinal length due to the friction maintained by the relatively more rigid sections R on a balloon portion of an angioplasty type balloon catheter. Accordingly, upon expansion, the constant length b, in conjunction with the generally constant length of the relatively flexible connector


250


, causes the stent


200


to maintain a relatively constant longitudinal dimension L in any diameter to which it is expanded. As can be appreciated, the maintenance of a constant length is desirable from the perspective of secure, repeatable placement of the stent within the vasculature.




Continuing to describe the stent


200


of

FIGS. 4 and 5

, the flexible sections F operate with the behavior of the flexible connectors


250


acting in the fashion of “N”-shaped flexible connectors of similar type. That is, the flexibility of the stent


200


is focused in this area F so that one is able to traverse tighter lesions using such a configuration. The relatively stronger sections R are capable of expansion to a stronger plastically deformed dimension, so that in this fashion the stent


200


is capable of supporting the arterial wall. Even though the longitudinal dimensions of the struts


210


,


220


in the relatively stronger sections R are of unequal length, such a configuration does not diminish radial support in the expanded condition. Accordingly, it can be appreciated that a stent of this shape will adequately support the arterial walls at the lesion site, while maintaining radial flexibility, and longitudinal length.




As can be best seen in

FIG. 7

, yet another alternate embodiment of the present invention is described. In

FIG. 7

, there is contained a stent


300


much like the Bx Velocity® stent sold by Cordis Corporation, Miami Lakes, Fla. In

FIG. 7

there is contained on the stent


300


generally flexible connector members


310


connected to generally rigid radial strut members


320


. The connector members


320


are generally formed in the shape of the letter “N”, and the struts


310


are generally slots formed in a radial fashion around the circumference of the stent. The connection made between the flexible connectors


320


and the radial strut members


310


is formed from a living hinge


330


. This living hinge


330


contains outer radial arc


332


and an inner radial arc


334


. In the expanded configuration, the radial arcs


332


,


334


move away one from the other, so that the overall length of the living hinge


330


actually increases upon expansion.




Known conventional means, such as angioplasty balloons, or the balloon on a stent delivery system expands the stent


300


of the present invention. Upon expansion, there are provided a number of benefits by the stent


300


of the present invention. First, as explained above, there is reduced foreshortening of the stent


300


, since the outer radial arc


332


in fact does not foreshorten. Since it lengthens slightly, the overall length of the stent


300


is maintained to its general nominal length. There is also provided increased radial strength since the radial arcs


332


,


334


at their connection between the flexible and radial struts


320


,


310


, (both inner and outer radial arcs


334


,


332


) combine to give superior strength in the arcs' section; the radial strut


310


provides for optimal strength in the radial direction since it is parallel to the loading direction of the stent


300


, thereby creating a “hoop” a circumference C of the stent. Also, because the radial arcs are able to accept greater forces, there is reduced strain for the equivalent strength designed for a stents. In all, the stent


300


of this embodiment provides for at least equivalent radial strength, less foreshortening and reduced strain when compared to current stents.




As can be seen from

FIGS. 8

,


9


and


10


, there is provided yet another embodiment of the stent


400


in the present invention. Again, the stent


400


provides for generally stronger radial sections R comprising radial struts


410


, which are generally slotted in alternating fashion around the circumference of the stent. The flexible connector members


420


are similar to the flexible connector members as seen in

FIG. 7

, and also to the flexible connector members of the Bx Velocity® stent. However, these flexible connector members


420


are connected to the radial struts generally somewhere near the midpoint of the radial struts


410


. In this fashion, upon expansion the length of the connector members


420


remains independent of the shortening or lengthening of the radial struts


410


. In this way, the overall length of the stent is maintained, as seen from the schematics in

FIGS. 9 and 10

.




Due to this overall ability to maintain the length of stent


400


, the radial struts


410


provide for radial strength only, and do not contribute in one way or another to any foreshortening of the stent. Also, the radial struts


410


are formed from a generally “wavy” pattern. This wavy pattern is useful in helping to reduce the crimp profile of the stent


400


on the balloon. This results from the relative smooth attachment of the radial struts


410


to the flexible connectors


420


. Further, having such an arrangement reduces the strain placed on the struts


420


upon expansion. This reduced strain is achieved due to the location of the connection of the struts


420


to the struts


410


. Because there is relatively little movement of the struts


420


in the longitudinal direction, there is relatively little strain placed on these struts during expansion. The radial arcs


415


of struts


410


can be ideally placed in a “shifted” configuration so that the stent is easier to crimp on a balloon.




Further, this can be seen from

FIG. 8

, that the radial strut members


410


are attached to the flexible connectors


420


so that the flexible connectors


420


generally proceed along a “spiral” pattern S around the length of the stent


400


. The connection points


422


of the flexible connectors


420


are placed in a diagonal fashion on struts


410


so as to enhance flexibility. Generally connectors


422


are located on a midpoint of a strut


410


. When the connectors


422


are placed past the midpoint of strut


410


(i.e., farther from the midpoint of strut


410


than from the direction of connector


420


), the nominal stent strength should increase upon expansion when compared to the above described stent. This arrangement reduces foreshortening, as described above. Further, the arrangement in no wise affects any torsion on the stent as it is applied to the lumen by the balloon catheter. Friction of the balloon to struts


410


maintains the struts


410


(and their opposite struts


420


) in the same general radial position throughout expansion. By reducing any concern of stent torsion, there is also a reduced concern of overall slippage of the balloon. Even though the connector members


420


are not aligned with one another, they are maintained in their respective positions on the balloon surface. Upon expansion, struts


420


lock into place, as the stent


400


is placed, giving an increased strength in the lumen.




From

FIGS. 8 and 9

, we see that the midpoint of a connector


420


is important to maintaining length. The greater the distance from connector


420


to the midpoint M, on the side of the connection between struts


410


,


420


, the greater the potential for shortening of the stent. This creates a need to solve any shortening by other means, absent the solution described herein.




It is to be understood that various modifications to the stent


400


of

FIGS. 8

,


9


and


10


are possible without departure from the invention herein. For instance, the connectors


420


can be placed intermittently about the stent


400


circumference, and not at every incidence of a radial strut


410


. Also, while the radial struts


410


are generally 90° out of phase between one series of struts


410




a


and the next


410




b


, it is foreseeable to place them between 30° to 150° out of place. When so placed, the struts


410


can be “encouraged” to bend in a particular fashion, which may be preferential in the design of a particularly intended stent.




These stents can be manufactured by know conventional means, such as laser etching, electrical discharge machining (EDM), photochemical etching, etc. However, there is also disclosed in the invention herein a novel method of performing photochemical resistance etching of the tube from which the stent is to be made. This novel method allows one to produce a stent with variable geometry in the three dimensions of the strut, that is, along its length, across the circumferential dimension, and along its depth (or radial dimension.) This method starts with a standard photochemical machining process.




The new process consists of cutting the stent using photochemical etching, cleaning it, and then coating it with a photoresist. The photoresist coating is applied in circular shapes


290


, as can be appreciated from FIG.


6


. These shapes


290


are intentionally figured to be of varying dimension in their radius. Then, a photoresist image is developed on the surface of the cylindrical metallic tube T from which the stent starts. This photoresist image is developed in a controlled fashion using known means. The development of the photoresist in this fashion allows a controlled variable etching rate at select positions along the cylindrical metallic tube.




As previously stated, the novel photoresist image can be seen in FIG.


6


. This photoresist image consists of a series of circular regions of photoresist material


310


, which are shaped in a variable diameter as desired for manufacture. These photoresist images


310


are configured at variable distances D from one another. As the diameter of the circular photoresist pattern


310


decreases, and its distance from other photoresist patterns


310


increases, the etching rate of that area of the stent increases. Thus, by strategically placing the photoresist patterns


310


on the stent, one can produce any variable dimension in any direction along the stent.




This photoresist pattern


310


variation results in a variation in the metal of the stent removed during the etching process. This process can be used to locally change the geometry of the metallic tube.




In this fashion, one can envision making a stent of variable circumferential width, radial depth or longitudinal length. As such, one can impart varying flexibilities along the stent longitude, as well as varying strengths so that a stent can be configured for emplacement at various locations within the body.



Claims
  • 1. A stent having a generally tubular shape and a longitudinal axis, comprising:a plurality of columnar sections and a plurality of flexible sections, each of said sections arranged circumferentially around said generally tubular shape, and a said columnar section attached to at least one flexible section, and said columnar section and flexible section each having predetermined longitudinal lengths, and wherein said columnar sections and said flexible sections each maintain their respective longitudinal lengths during expansion of the stent from a first unexpanded configuration to a second expanded configuration.
  • 2. The stent of claim 1 wherein consecutive flexible sections are out of phase with one another.
  • 3. The stent of claim 1 wherein the flexible sections have an axis that is non-parallel to the longitudinal axis of the stent.
  • 4. The stent of claim 3 wherein consecutive flexible sections are out of phase with one another.
  • 5. The stent of claim 3 wherein the flexible sections are connected to columnar sections by means of connector members, said connector members placed out of phase with one another.
  • 6. The stent of claim 1 wherein the flexible sections have an axis parallel to the longitudinal axis of the stent.
  • 7. The stent of claim 6 wherein consecutive flexible sections are out of phase with one another.
  • 8. The stent of claim 6 wherein the flexible sections are connected to columnar sections by connector members, said connector members placed out of phase with one another.
  • 9. The stent of claim 1 wherein the flexible sections are connected to columnar sections by connector members, said connector members placed out of phase with one another.
Parent Case Info

This Application claims the benefit to U.S. provisional application Ser. No. 60/272,696 filed Mar. 1, 2001.

US Referenced Citations (118)
Number Name Date Kind
1205743 Didcott Jul 1966 A
3657744 Ersek Apr 1972 A
4441216 Ionescu et al. Apr 1984 A
4503569 Dotter Mar 1985 A
4553545 Maass et al. Nov 1985 A
4580568 Gianturco Apr 1986 A
4733665 Palmaz Mar 1988 A
4776337 Palmaz Oct 1988 A
4800882 Gianturco Jan 1989 A
4856516 Hillstead Aug 1989 A
4886062 Wiktor Dec 1989 A
4907336 Gianturco Mar 1990 A
4969458 Wiktor Nov 1990 A
4990131 Dardik et al. Feb 1991 A
4990155 Wilkoff Feb 1991 A
4994071 MacGregor Feb 1991 A
5015253 MacGregor May 1991 A
5035706 Gianturco et al. Jul 1991 A
5041126 Gianturco Aug 1991 A
5064435 Porter Nov 1991 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5116365 Hillstead May 1992 A
5122154 Rhodes Jun 1992 A
5131908 Dardik et al. Jul 1992 A
5133732 Wiktor Jul 1992 A
5135536 Hillstead Aug 1992 A
5163958 Pinchuk Nov 1992 A
5171262 MacGregor Dec 1992 A
5176660 Truckai Jan 1993 A
5178618 Kandarpa Jan 1993 A
5192307 Wall Mar 1993 A
5195984 Schatz Mar 1993 A
5217483 Tower Jun 1993 A
5222971 Willard et al. Jun 1993 A
5246445 Yachia et al. Sep 1993 A
5258021 Duran Nov 1993 A
5266073 Wall Nov 1993 A
5275622 Lazarus et al. Jan 1994 A
5282823 Schwartz et al. Feb 1994 A
5282824 Gianturco Feb 1994 A
5290305 Inoue Mar 1994 A
5292331 Boneau Mar 1994 A
5304200 Spaulding Apr 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5334301 Heinke et al. Aug 1994 A
5342387 Summers Aug 1994 A
5354257 Roubin et al. Oct 1994 A
5354308 Simon et al. Oct 1994 A
5366504 Andersen et al. Nov 1994 A
5370683 Fontaine Dec 1994 A
5370691 Samson Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5376112 Duran Dec 1994 A
5382261 Palmaz Jan 1995 A
5387235 Chuter Feb 1995 A
5389106 Tower Feb 1995 A
5395390 Simon et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5403341 Solar Apr 1995 A
5405377 Cragg Apr 1995 A
5411549 Peters May 1995 A
D359802 Fontaine Jun 1995 S
5421955 Lau et al. Jun 1995 A
5423885 Williams Jun 1995 A
5441515 Khosravi et al. Aug 1995 A
5441516 Wang et al. Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443496 Schwartz et al. Aug 1995 A
5443498 Fontaine Aug 1995 A
5443500 Sigwart Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
5449373 Pinchasik et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5496365 Sgro Mar 1996 A
5527354 Fontaine et al. Jun 1996 A
5569295 Lam Oct 1996 A
5591197 Orth et al. Jan 1997 A
5632763 Glastra May 1997 A
5643312 Fischell et al. Jul 1997 A
5649952 Lam Jul 1997 A
5653747 Dereume Aug 1997 A
5669924 Shaknovich Sep 1997 A
5697971 Fischell et al. Dec 1997 A
5733303 Israel et al. Mar 1998 A
5755734 Richter et al. May 1998 A
5776161 Globerman Jul 1998 A
5800508 Goicoechea et al. Sep 1998 A
5807404 Richter Sep 1998 A
5836964 Richter et al. Nov 1998 A
5843120 Israel et al. Dec 1998 A
5861027 Trapp Jan 1999 A
5876449 Starck et al. Mar 1999 A
5913895 Burpee et al. Jun 1999 A
5922020 Klein et al. Jul 1999 A
5935162 Dang Aug 1999 A
5972018 Israel et al. Oct 1999 A
6001123 Lau Dec 1999 A
6017365 Von Oepen Jan 2000 A
6019789 Dinh et al. Feb 2000 A
6033435 Penn et al. Mar 2000 A
6059811 Pinchasik et al. May 2000 A
6090127 Globerman Jul 2000 A
6123721 Jang Sep 2000 A
6129754 Kanesaka et al. Oct 2000 A
6171334 Cox Jan 2001 B1
6179867 Cox Jan 2001 B1
6190405 Culombo Feb 2001 B1
6193747 Von Oepen Feb 2001 B1
6203569 Wijay Mar 2001 B1
6217608 Penn et al. Apr 2001 B1
6231598 Berry et al. May 2001 B1
6293967 Shanley Sep 2001 B1
6309414 Rolando et al. Oct 2001 B1
6325821 Gaschino Dec 2001 B1
6340366 Wijay Jan 2002 B2
6344055 Shukov Feb 2002 B1
Foreign Referenced Citations (19)
Number Date Country
3205942 Sep 1983 DE
0 540 290 May 1993 EP
0 540 290 May 1993 EP
0 734 698 Oct 1996 EP
0 800 801 Oct 1997 EP
0 830 853 Mar 1998 EP
0 887 051 Dec 1998 EP
1074 227 Feb 2001 EP
566807 Feb 1924 FR
6-41745 Jun 1994 JP
WO 9626689 Sep 1996 WO
WO 9634580 Nov 1996 WO
WO 9725000 Jul 1997 WO
WO 9732544 Sep 1997 WO
9732544 Sep 1997 WO
WO 9819628 May 1998 WO
WO 9949928 Oct 1999 WO
WO 0062710 Oct 2000 WO
WO 0066034 Nov 2000 WO
Non-Patent Literature Citations (1)
Entry
European Search Report, dated Oct. 16, 2002, for European Appln. No. EP 02 25 1428.
Provisional Applications (1)
Number Date Country
60/272696 Mar 2001 US